TEHR vs MyOrbitHealth: Costs, Scope and Buyer Fit

How do TEHR and MyOrbitHealth compare as of October 22, 2026?

This table separates vendor statements from unanswered questions. “Not stated on reviewed pages” means the public evidence did not establish an answer; it does not mean the capability is unavailable. Confirm the exact product, state coverage and service obligations in a written proposal.

Are you buying a ready brand or embedding a clinical layer?

Start with the asset you intend to keep. A new entrepreneur may need a branded patient experience and operational coordination. An established healthcare business may already have a storefront, membership system and care team that work. Replacing everything can destroy more value than it creates. Conversely, keeping an awkward checkout simply because it exists can leave the new clinical service trapped behind old processes. Write down which parts of the current experience must remain, which can change and who controls each integration.

MyOrbitHealth describes both hosted and embedded routes on its platform page. That makes implementation style an important selection question. TEHR should be evaluated against your actual route through the TEHR platform, rather than against an imagined software-only alternative. Ask each team to demonstrate the point where an authorized clinical decision becomes an order, an invoice and a patient notification. If those events disagree, identify the team responsible for fixing them before you sign.

How should you compare fees without confusing price with margin?

A monthly fee is only one line in the operating model. Your estimate should separately include implementation, clinical encounters, pharmacy charges, shipping, testing, payment processing, software extras and staff effort. Divide costs into fixed commitments, usage-based charges and optional services. Then run the same patient assumptions through both proposals. A business with expensive acquisition and weak retention can lose money on an inexpensive platform; a mature membership base may care more about refill reliability than the lowest entry price.

The current MyOrbitHealth pricing page provides a starting tier and higher packages, while its FAQ still says only the model is published. Ask which written schedule controls your quote. TEHR’s pricing model is a flat subscription plus flat transaction fee and 0% revenue share; contact TEHR for a scoped quote. Neither zero revenue share nor a published subscription establishes lower total cost. Include one low-volume month, one growth month and a month with unusually high support demand.

What should a lab-dependent brand test before deciding?

For hormone or longevity programs, a failed lab handoff can interrupt the whole customer relationship. The useful question is not merely whether a platform connects to labs. Ask how the provider orders a panel, how the patient selects collection, how an unusable sample is handled, and how the result becomes visible to the clinician responsible for follow-up. A result should not disappear into a general inbox while billing continues as if treatment were progressing normally.

MyOrbitHealth describes three collection routes on its Orbit Labs page; mobile availability depends on location. Build a demo around your real patient geography and intended panels. For TEHR, confirm the exact diagnostic workflow in a proposal rather than assuming a standalone lab product is available. Use our diagnostic lab brand guide to frame the operational questions. Ask for the ordering entity, review responsibility, specimen exceptions, test charges and communication process in the proposal, not merely a logo on an integrations slide.

How do you separate patient migration from data export?

An export clause protects an exit option. It does not prove that another platform can import the files correctly or continue care without additional work. A migration must reconcile active treatment status, consent, clinical documentation, subscriptions, payment references, pharmacy history and unresolved support cases. Some records remain with the original care entity under its retention obligations. The destination needs the information and permissions required to operate, not an indiscriminate copy of every old database field.

MyOrbitHealth’s published terms summary describes data export, but the reviewed pages did not establish an inbound migration package. TEHR’s operators have migrated thousands of their own patients. Use the patient migration checklist to define a test cohort, reconcile record counts and confirm the next billing and refill event. Require a rollback decision and named owners. Avoid treating an uploaded spreadsheet as evidence that clinical, pharmacy and financial continuity have all been solved.

When should you choose TEHR?

Choose TEHR for a closer evaluation when you want a branded operating platform and a team whose stated experience comes from running consumer health brands. The relevant operator history includes DudeMeds, Peptiders, TellyMeds and FansMeds. That history is a reason to ask specific operational questions, not a substitute for product evidence. Have the team explain how it handles pending intake, failed payment, clinician requests for more information, pharmacy exceptions and a patient who wants to cancel while an order is already in progress.

TEHR is a stronger fit for your requirements only if its written scope, workflow demonstration and migration plan match what you need. The independent provider makes clinical decisions; the brand cannot buy guaranteed prescriptions. Patients use the brand experience while required legal notices identify the actual care entities. Read what white-label telehealth includes and use the same acceptance criteria for both vendors. Ask TEHR to quote any support work your existing team cannot absorb.

When should you choose MyOrbitHealth?

Choose MyOrbitHealth for a closer evaluation when its documented implementation choices or lab collection routes match a requirement you already understand. For example, a technology team retaining its own patient application has different priorities from an operator who wants a managed storefront. A provider-led program serving patients far from draw centers may place unusual weight on collection logistics. Those are concrete reasons to shortlist a vendor; they are more useful than declaring one platform universally best.

Before committing, resolve the exact tier, onboarding deliverables, clinical coverage and variable charges. An API mention does not prove that every needed event, document and administrative action is exposed. Ask for a working integration example and a definition of what happens when your system is unavailable. Review other MyOrbitHealth alternatives if the choice is really between a hosted platform, a clinician service and practice software. Those purchases should not be forced into the same price comparison.

What evidence should decide the final selection?

Give both teams a short script rather than accepting an unrestricted sales tour. Include a new eligible patient, a patient who needs more clinical information, a failed payment, a delayed shipment and an established patient arriving through migration. Observe what the patient sees, what the operator can change and what remains solely under clinical control. Record the person or organization accountable for each unresolved handoff.

The final decision packet should contain the service scope, itemized economics, state/program coverage, implementation milestones, data responsibilities and support escalation rules. For planned peptide programs, TEHR’s status is pending and not open for prescribing or fulfillment; regulatory news does not automatically activate an offering. Keep a product roadmap separate from available services. The TEHR resources hub provides related planning material, but the contract and demonstrated workflows should settle the purchase. If a requirement cannot be shown or committed to, carry it as an unresolved item rather than assuming it will work after launch.

What else should you know?